Mounjaro vs Ozempic vs Wegovy in Malaysia: Price, Results & Which to Choose
All three are weekly injectable GLP-1-based medicines sold in Malaysia with a prescription, but they differ sharply on price, strength and approval: Mounjaro (tirzepatide) and Wegovy (higher-dose semaglutide) are approved for weight management, Ozempic (semaglutide) is approved for type 2 diabetes and used off-label for weight loss, and DoctorOnCall’s own RM-per-month pricing not the US/UK figures most comparison sites quote — is what decides the real cost in Malaysia.
Mounjaro vs Ozempic vs Wegovy: At a Glance
| Mounjaro | Ozempic | Wegovy | |
|---|---|---|---|
| Active ingredient | Tirzepatide (dual GIP/GLP-1) | Semaglutide | Semaglutide (higher dose) |
| Approved use | Weight management | Type 2 diabetes (used off-label for weight loss) | Weight management |
| Dosing | Weekly, 2.5–15mg | Weekly, 0.25–1mg (dial pen) | Weekly, 0.25–2.4mg |
| Entry price (1 pen, DoctorOnCall) | RM1,259.20 (2.5mg) | RM1,049.00 | RM1,052.00 (0.25mg) |
| Entry 0% instalment | From RM53/month | From RM44/month | From RM44/month |
| Top-dose price (1 pen) | RM3,397.65 (15mg) | Price set by dial, not separate SKU | RM1,708.00 (2.4mg) |
| Prescription status | Rx only | Rx only | Rx only |
Prices shown are DoctorOnCall’s own listed per-pen prices as of October 2026 not the US/UK figures most comparison articles quote, which don’t reflect what you’d actually pay in Malaysia.
Effectiveness and Side Effects
Weight loss results. In head-to-head and placebo-controlled trials, tirzepatide (Mounjaro) has generally produced greater average weight loss than semaglutide at approved doses, largely because it acts on two gut hormone pathways (GIP and GLP-1) instead of one. Wegovy (higher-dose semaglutide) is dosed and approved specifically for weight management, while Ozempic is approved for type 2 diabetes and produces weight loss as a secondary effect at its lower approved doses. Individual results vary significantly by person, diet and activity level these are population averages from clinical trials, not a guarantee.
Side effects. All three share a similar side-effect profile because they work on related hormone pathways: nausea, vomiting, diarrhoea, constipation and reduced appetite are the most common, especially during the first few weeks and right after a dose increase. Rare but serious risks (e.g. pancreatitis, gallbladder problems, thyroid tumours in animal studies) are listed in the patient information leaflet for each medicine and should be discussed with your doctor, particularly if you have a personal or family history of thyroid cancer.
Bottom line: none of the three is “safer” in a way that applies to everyone the right choice depends on your health history, your goal (diabetes control vs weight loss), and how you tolerate the medicine, which is why a doctor’s review is required before any of them can be prescribed.
Which Should You Choose?
- You have type 2 diabetes and want glycemic control first, weight loss second: Ozempic is the medicine specifically approved for this.
- Your main goal is weight management and you want the strongest average results: Mounjaro’s dual-hormone action tends to produce the largest average weight loss of the three.
- Your main goal is weight management and you prefer the most established GLP-1-only option: Wegovy is semaglutide dosed specifically for weight loss.
- Budget is the deciding factor: Ozempic and Wegovy both start lower (around RM1,049–RM1,052 per pen, RM44/month on instalment) than Mounjaro’s entry dose (RM1,259.20, RM53/month) see the full [Mounjaro price breakdown] for every strength.
Whichever you’re considering, the next steps are the same: a doctor confirms which medicine and starting dose suit your health history, then issues the prescription. See our guides on how to buy Mounjaro online in Malaysia and the Mounjaro KwikPen dosage and titration schedule for what happens after you decide.
Frequently Asked Questions
Which is strongest: Mounjaro, Ozempic or Wegovy?
Mounjaro (tirzepatide) has generally shown the greatest average weight loss in clinical trials, because it acts on two hormone pathways instead of one. Individual results vary.
Which is cheapest in Malaysia?
At entry dose, Ozempic and Wegovy are slightly cheaper per pen (around RM1,049–RM1,052) than Mounjaro’s starting 2.5mg pen (RM1,259.20). All three offer 0% instalments on DoctorOnCall.
Can I switch between Mounjaro, Ozempic and Wegovy?
Only under a doctor’s supervision. Switching GLP-1-based medicines involves re-assessing your dose and titration schedule — don’t switch on your own.
Is Ozempic approved for weight loss in Malaysia?
Ozempic is approved for type 2 diabetes; any weight-loss use is considered off-label and should be discussed with your doctor. Wegovy and Mounjaro are the options specifically approved for weight management.
Do all three require a prescription?
Yes, all three are prescription-only medicines in Malaysia.
Find Your Right Fit
Get a free online doctor consultation to find out which of Mounjaro, Ozempic or Wegovy suits your health goals and history with 0% instalments and cold-chain delivery on every order.
